Vaxcyte Inc (NASDAQ:PCVX)
| 53.87 Delayed Data As of Dec 01 |  +2.10 / +4.06%Today’s Change | 34.11 Today|||52-Week Range 54.97 | +12.35% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Pickering Grant E Chief Executive Officer |  Sale | 9/25/2023 | 15,000 | $52.45 | $786.8K | +5.84% |
Pickering Grant E Chief Executive Officer | Sale | 11/24/2023 | 11,221 | $48.96 | $549.4K | +9.08% |
Pickering Grant E Chief Executive Officer | Sale | 9/05/2023 | 10,378 | $51.00 | $529.3K | +5.51% |
Pickering Grant E Chief Executive Officer | Sale | 10/23/2023 | 11,236 | $46.98 | $527.9K | +14.73% |
Eydelman Mikhail General Counsel & Senior Vice President |  Buy | 10/02/2023 | 20,000 | $21.41 | $428.2K | +9.73% |
Guggenhime Andrew L President & Chief Financial Officer | Sale | 11/20/2023 | 7,876 | $51.12 | $402.6K | +4.67% |
Eydelman Mikhail General Counsel & Senior Vice President | Sale | 10/02/2023 | 7,992 | $49.58 | $396.2K | +9.73% |
Eydelman Mikhail General Counsel & Senior Vice President | Sale | 10/02/2023 | 7,134 | $51.44 | $367.0K | +9.73% |
Guggenhime Andrew L President & Chief Financial Officer | Sale | 10/18/2023 | 7,497 | $45.88 | $344.0K | +16.90% |
Wassil Jim Chief Operating Officer | Buy | 12/23/2022 | 105,371 | $2.42 | $255.0K | +15.30% |
Page of 8